language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
SOLVSOLV

$73.83

-0.05
arrow_drop_down0.07%
Current Market·update12 Nov 2025 21:00

$72.0

-1.83
arrow_drop_down2.48%
Pre-market·update13 Nov 2025 13:50
Day's Range
73.39-74.71
52-week Range
60.7-85.92

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-06
Next Earnings TimeAfter Market Close
Volume1M
Average Volume 30d1.15M

AI SOLV Summary

Powered by LiveAI
💰
25.5
Valuation (P/E Ratio)
Reasonable for growth sector
📈
0.152
EPS Growth (YoY)
Strong earnings growth
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
78

Solventum shows a mixed profile with strong fundamental and thematic potential, tempered by current technical indicators suggesting some caution. It represents a solid long-term growth opportunity within the healthcare sector.

Very Strong

Thematic

85

Solventum is well-positioned to benefit from several key secular trends in healthcare, including advancements in medical devices, data management, and patient care solutions.

Strong

Fundamental

80

Solventum exhibits solid financial health with a manageable debt level and robust revenue generation, though recent quarterly profitability and valuation metrics warrant close monitoring.

Neutral to Cautious

Technical

65

Solventum's stock exhibits mixed short-term technical signals. While it has shown positive performance over the last year, recent trends and indicators suggest a period of consolidation or potential pullback.

FactorScore
Healthcare Innovation & Technology90
Aging Population & Increased Healthcare Spending92
Digital Health & Health Information Systems88
Regulatory Environment (Healthcare)70
Supply Chain Resilience & Manufacturing75
FactorScore
Valuation50
Profitability60
Growth85
Balance Sheet Health55
Cash Flow75
FactorScore
Trend Analysis80
Momentum40
Volume Confirmation60
Support & Resistance50
Moving Averages50

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Earnings Performance chevron_right

Positive Earnings Surprises

Solventum Corporation has consistently beaten earnings per share (EPS) estimates, with recent quarters showing surprises of 9.72%, 6.68%, and 17.67%. This suggests strong operational execution and better-than-expected profitability.

Valuation chevron_right

Growth Prospects Justify Valuation

The company's P/E ratio is 34.07 (TTM). While seemingly high, the historical revenue growth and positive EPS surprises indicate potential for continued growth that could support this valuation.

Show More 🔒
thumb_down

Bearish Points (6)

Valuation chevron_right

High Quarterly P/E Ratios

Recent quarterly P/E ratios (e.g., Q1 2025 at 96.0, Q4 2024 at 368.7) are exceptionally high. This suggests that current earnings are not keeping pace with the stock price, potentially indicating overvaluation if future growth expectations are not met.

Growth Deceleration chevron_right

Declining Net Margins

Net profit margins have significantly decreased from 17.9% in 2021 to 5.8% in 2024 (annual). This trend, along with a sharp drop in Q4 2024 net margin to 1.5%, indicates potential margin compression and challenges in converting revenue to profit.

Show More 🔒

Calendar

August 2025

8

Next Earnings Date

EPS Est.
Revenue Est.

H: $1.49

A: $1.45

L: $1.36

H: 2.13B

A: 2.12B

L: 2.11B

Profile

Employees (FY)22K
ISIN-
FIGI-

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Seasonals

Price Target

85.04 USD

The 39 analysts offering 1 year price forecasts for SOLV have a max estimate of 103.00 and a min estimate of 71.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
138M (79.96%)
Closely held shares
34.7M (20.04%)
173M
Free Float shares
138M (79.96%)
Closely held shares
34.7M (20.04%)

Capital Structure

Market cap
12.93B
Debt
8.01B
Minority interest
0.00
Cash & equivalents
762M
Enterprise value
20.18B

Valuation - Summary

Market Cap
12.9B
Net income
290M(2.24%)
Revenue
6.23B(48.15%)
12.9B
Market Cap
12.9B
Net income
290M(2.24%)
Revenue
6.23B(48.15%)
Price to earning ratio (P/E)44.60x
Price to sales ratio (P/S)2.10x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
8.25B
COGS
3.66B
Gross Profit
4.59B
OpEx
3.56B
Operating Income
1.04B
Other & Taxes
557M
Net Income
479M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒